Zhong Lan Wei

Director/Miembro de la Junta en ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD. .

44 años

Health Technology

Perfil

Zhong Lan Wei currently works at Zhejiang Garden Biopharmaceutical Co., Ltd., as Vice Chairman from 2022 and Zhejiang Garden Pharmaceutical Co., Ltd., as Executive Director from 2021.

Cargos activos de Zhong Lan Wei

Empresas	Cargo	Inicio
ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.	Director/Miembro de la Junta	19/04/2022
Zhejiang Garden Pharmaceutical Co., Ltd. Zhejiang Garden Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Garden Pharmaceutical Co., Ltd. is engaged in manufacture pharmaceutical products including Xinnaojian tablets, panaxnotoginseng capsules, sucralfate tablets and Lansoprazole.The company leading product is Xinnaojian traditional chinese tablet, it can be used in the therapy of cardiovascular and cerebrovascular diseases (high blood pressure, hyperlipemia) and cytopenia caused by the teletherapy and chemotherapy of tumor. The company was founded in August, 2001 and is headquartered in Dongyang China.	Director/Miembro de la Junta	29/09/2021

Todos los cargos activos de Zhong Lan Wei

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Zhong Lan Wei.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.	Health Technology

Empresas privadas	1
Zhejiang Garden Pharmaceutical Co., Ltd. Zhejiang Garden Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Garden Pharmaceutical Co., Ltd. is engaged in manufacture pharmaceutical products including Xinnaojian tablets, panaxnotoginseng capsules, sucralfate tablets and Lansoprazole.The company leading product is Xinnaojian traditional chinese tablet, it can be used in the therapy of cardiovascular and cerebrovascular diseases (high blood pressure, hyperlipemia) and cytopenia caused by the teletherapy and chemotherapy of tumor. The company was founded in August, 2001 and is headquartered in Dongyang China.	Health Technology